Effective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia

Eur J Cancer. 2019 Nov:121:94-97. doi: 10.1016/j.ejca.2019.08.024. Epub 2019 Sep 27.

Authors

Min Chul Choi¹, Jisu Oh², Chan Lee¹

Affiliations

¹ Department of Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam-si, Gyeonggi-do, South Korea.
² Hemato-Oncology, CHA Bundang Medical Center, CHA University, Seongnam-si, Gyeonggi-do, South Korea. Electronic address: fascia5@chamc.co.kr.

PMID: 31569067
DOI: 10.1016/j.ejca.2019.08.024

No abstract available

Keywords: Epithelioid trophoblastic tumour; Gestational trophoblastic neoplasia; MSI; PD-1; Pembrolizumab; Placental site trophoblastic tumour.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't
Review

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / therapeutic use*
Drug Resistance, Neoplasm / drug effects*
Female
Gestational Trophoblastic Disease / drug therapy*
Gestational Trophoblastic Disease / pathology
Humans
Middle Aged
Pregnancy
Programmed Cell Death 1 Receptor / antagonists & inhibitors
Programmed Cell Death 1 Receptor / immunology
Remission Induction / methods
Treatment Outcome
Uterine Neoplasms / drug therapy*
Uterine Neoplasms / pathology

Substances

Antibodies, Monoclonal, Humanized
Programmed Cell Death 1 Receptor
pembrolizumab